Tramadol Hydrochloride Tablet, Film Coated
Product Images NDC 87063-117

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 87063-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E43a14b1 3c3c 4d97 A157 E118a29d1800 01)

FDA Label Image

Image (E43a14b1 3c3c 4d97 A157 E118a29d1800 02)

FDA Label Image

Figure 2 (E43a14b1 3c3c 4d97 A157 E118a29d1800 03)

Figure 2 (E43a14b1 3c3c 4d97 A157 E118a29d1800 03)
This text provides data on the percentage of participants discontinuing treatment over time in a clinical trial. The chart shows a decrease in the discontinuation rate over the course of the study, with specific focus on discontinuations due to nausea and vomiting. The study is identified by the protocol code CAPSS-047 and looks at the time to discontinuation in days during the double-blind phase.*
FDA Label Image

1 (Label)

1 (Label)
This is not-available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.